United States · Venture startup

Who invested in Bright Uro

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Medical Devices

Funding summaryUpdated 26 Oct 2026

$15Mraised across 1 round since 2025, from 1 source

Latest round
Venture, $15MJul 2025
Investors
1
See who backed them

The rounds

  1. Jul 2025
    Venture$15M

    Source recordedSEC filing: $15M sold, first sale Jun 2025

Founders and team

From Bright Uro's own website: 1 founder, 5 on the team.

Derek HerreraFounder & Chief Executive Officer
  • Casey KanelChief Commercial Officer
  • Henky WibowoChief Technology Officer
  • Kevin HershbergerChief Financial Officer
  • Scott MacDiarmidChief Medical Officer
  • Tracy MaahsChief Operations Officer

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Bright Uro as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

AIN VenturesVC firmPer its own site

Quick answers about Bright Uro

Who invested in Bright Uro?

Bright Uro's investors include National Institutes of Health.

How much has Bright Uro raised?

Bright Uro has raised $15M across 1 round since 2025.

When did Bright Uro last raise?

Bright Uro's most recent round was a Venture of $15M in Jul 2025.

What was Bright Uro's biggest round?

Its most recent round, $15M in Jul 2025, is also its largest on record.

Who backed Bright Uro first?

Bright Uro's first round on record, in Jul 2025, was backed by National Institutes of Health.

What stage is Bright Uro at?

Bright Uro's latest named round is a Venture, in Jul 2025.

Where is Bright Uro based?

Bright Uro is based in the United States.

Companies like Bright Uro

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.